Cargando…

Challenges facing translational research organizations in China: a qualitative multiple case study

BACKGROUND: Translational medicine is attracting much attention worldwide and many translational research organizations (TROs) have been established. In China, translational medicine has developed rapidly, but faces many challenges. This study was aimed at exploring these challenges faced by emergin...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Laixin, Li, Ying, Bosworth, Hayden B, Ehiri, John, Luo, Changkun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853359/
https://www.ncbi.nlm.nih.gov/pubmed/24119837
http://dx.doi.org/10.1186/1479-5876-11-256
_version_ 1782478816557400064
author Zhou, Laixin
Li, Ying
Bosworth, Hayden B
Ehiri, John
Luo, Changkun
author_facet Zhou, Laixin
Li, Ying
Bosworth, Hayden B
Ehiri, John
Luo, Changkun
author_sort Zhou, Laixin
collection PubMed
description BACKGROUND: Translational medicine is attracting much attention worldwide and many translational research organizations (TROs) have been established. In China, translational medicine has developed rapidly, but faces many challenges. This study was aimed at exploring these challenges faced by emerging TROs in China. METHOD: A qualitative, multiple case study approach was used to assess the challenges faced by TROs in China. Data were collected between May and August 2012. RESULTS: Eight cases were identified. Overall, four themes that characterized TROs in China emerged from analyses: 1. objectives, organizer, and funding resources, 2. participating partners and research teams, 3. management, and 4. achievements. All TROs had objectives related to translating basic discovery to clinic treatment and cultivating translational researchers. In terms of organizer and funding resources, 7 out of 8 TROs were launched only by universities and/or hospitals, and funded mostly through research grants. As for participating partners and multidisciplinary research teams, all but one of the TROs only involved biomedical research institutions who were interested in translational research, and characterized as clinical research centers; 7 out of 8 TROs involved only researchers from biomedicine and clinical disciplines and none involved disciplines related to education, ethnicity, and sociology, or engaged the community. Current management of the TROs were generally nested within the traditional research management paradigms, and failed to adapt to the tenets of translational research. Half of the TROs were at developmental stages defined as infrastructure construction and recruitment of translational researchers. CONCLUSIONS: TROs in China face the challenge of attracting sustainable funding sources, widening multidisciplinary cooperation, cultivating multi-disciplinary translational researchers and adapting current research management to translational research. Greater emphasis should be placed on increasing multidisciplinary cooperation, and innovating in education programs to cultivate of translational researchers. Efforts should be made to reform research management in TROs, and establish sustainable funding resources.
format Online
Article
Text
id pubmed-3853359
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-38533592013-12-07 Challenges facing translational research organizations in China: a qualitative multiple case study Zhou, Laixin Li, Ying Bosworth, Hayden B Ehiri, John Luo, Changkun J Transl Med Research BACKGROUND: Translational medicine is attracting much attention worldwide and many translational research organizations (TROs) have been established. In China, translational medicine has developed rapidly, but faces many challenges. This study was aimed at exploring these challenges faced by emerging TROs in China. METHOD: A qualitative, multiple case study approach was used to assess the challenges faced by TROs in China. Data were collected between May and August 2012. RESULTS: Eight cases were identified. Overall, four themes that characterized TROs in China emerged from analyses: 1. objectives, organizer, and funding resources, 2. participating partners and research teams, 3. management, and 4. achievements. All TROs had objectives related to translating basic discovery to clinic treatment and cultivating translational researchers. In terms of organizer and funding resources, 7 out of 8 TROs were launched only by universities and/or hospitals, and funded mostly through research grants. As for participating partners and multidisciplinary research teams, all but one of the TROs only involved biomedical research institutions who were interested in translational research, and characterized as clinical research centers; 7 out of 8 TROs involved only researchers from biomedicine and clinical disciplines and none involved disciplines related to education, ethnicity, and sociology, or engaged the community. Current management of the TROs were generally nested within the traditional research management paradigms, and failed to adapt to the tenets of translational research. Half of the TROs were at developmental stages defined as infrastructure construction and recruitment of translational researchers. CONCLUSIONS: TROs in China face the challenge of attracting sustainable funding sources, widening multidisciplinary cooperation, cultivating multi-disciplinary translational researchers and adapting current research management to translational research. Greater emphasis should be placed on increasing multidisciplinary cooperation, and innovating in education programs to cultivate of translational researchers. Efforts should be made to reform research management in TROs, and establish sustainable funding resources. BioMed Central 2013-10-13 /pmc/articles/PMC3853359/ /pubmed/24119837 http://dx.doi.org/10.1186/1479-5876-11-256 Text en Copyright © 2013 Zhou et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Zhou, Laixin
Li, Ying
Bosworth, Hayden B
Ehiri, John
Luo, Changkun
Challenges facing translational research organizations in China: a qualitative multiple case study
title Challenges facing translational research organizations in China: a qualitative multiple case study
title_full Challenges facing translational research organizations in China: a qualitative multiple case study
title_fullStr Challenges facing translational research organizations in China: a qualitative multiple case study
title_full_unstemmed Challenges facing translational research organizations in China: a qualitative multiple case study
title_short Challenges facing translational research organizations in China: a qualitative multiple case study
title_sort challenges facing translational research organizations in china: a qualitative multiple case study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853359/
https://www.ncbi.nlm.nih.gov/pubmed/24119837
http://dx.doi.org/10.1186/1479-5876-11-256
work_keys_str_mv AT zhoulaixin challengesfacingtranslationalresearchorganizationsinchinaaqualitativemultiplecasestudy
AT liying challengesfacingtranslationalresearchorganizationsinchinaaqualitativemultiplecasestudy
AT bosworthhaydenb challengesfacingtranslationalresearchorganizationsinchinaaqualitativemultiplecasestudy
AT ehirijohn challengesfacingtranslationalresearchorganizationsinchinaaqualitativemultiplecasestudy
AT luochangkun challengesfacingtranslationalresearchorganizationsinchinaaqualitativemultiplecasestudy